A new trading day began on Tuesday, with MAIA Biotechnology Inc (AMEX: MAIA) stock price up 5.82% from the previous day of trading, before settling in for the closing price of $1.89. MAIA’s price has ranged from $1.24 to $5.99 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -7.69%. With a float of $21.06 million, this company’s outstanding shares have now reached $23.97 million.
The extent of productivity of a business whose workforce counts for 13 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
MAIA Biotechnology Inc (MAIA) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of MAIA Biotechnology Inc is 16.87%, while institutional ownership is 5.79%. The most recent insider transaction that took place on Dec 13 ’24, was worth 46,800. In this transaction Director of this company bought 25,000 shares at a rate of $1.87, taking the stock ownership to the 1,130,060 shares. Before that another transaction happened on Dec 13 ’24, when Company’s Director bought 53,418 for $1.87, making the entire transaction worth $99,998. This insider now owns 514,970 shares in total.
MAIA Biotechnology Inc (MAIA) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.25 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -7.69% per share during the next fiscal year.
MAIA Biotechnology Inc (AMEX: MAIA) Trading Performance Indicators
Here are MAIA Biotechnology Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.56.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.34, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -1.35 in one year’s time.
Technical Analysis of MAIA Biotechnology Inc (MAIA)
The latest stats from [MAIA Biotechnology Inc, MAIA] show that its last 5-days average volume of 0.98 million was superior to 0.5 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 48.47%. Additionally, its Average True Range was 0.17.
During the past 100 days, MAIA Biotechnology Inc’s (MAIA) raw stochastic average was set at 14.29%, which indicates a significant decrease from 47.37% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 47.30% in the past 14 days, which was lower than the 76.68% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.0600, while its 200-day Moving Average is $2.8300. Now, the first resistance to watch is $2.2200. This is followed by the second major resistance level at $2.4300. The third major resistance level sits at $2.5700. If the price goes on to break the first support level at $1.8700, it is likely to go to the next support level at $1.7300. Assuming the price breaks the second support level, the third support level stands at $1.5200.
MAIA Biotechnology Inc (AMEX: MAIA) Key Stats
With a market capitalization of 50.66 million, the company has a total of 26,158K Shares Outstanding. Currently, annual sales are 0 K while annual income is -19,770 K. The company’s previous quarter sales were 0 K while its latest quarter income was -2,740 K.
